saikosaponin d has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujikawa-Yamamoto, K; Odashima, S; Tanino, M; Teraoka, K; Yamagishi, H; Zong, Z | 1 |
| Fujikawa-Yamamoto, K; Guan, X; Li, A; Murakami, M; Odashima, S; Ota, T; Tanino, M; Yamaguchi, N; Zong, Z | 1 |
2 other study(ies) available for saikosaponin d and B16 Melanoma
| Article | Year |
|---|---|
Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line; Cell Nucleus; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; Kinetics; Melanoma, Experimental; Mice; Oleanolic Acid; Protein Kinase C; Sapogenins; Saponins; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1996 |
Saikosaponin b2 induces differentiation without growth inhibition in cultured B16 melanoma cells.
Topics: Animals; Cell Cycle; Cell Differentiation; Cell Size; Fluorescent Antibody Technique; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Neoplasm Transplantation; Oleanolic Acid; Sapogenins; Saponins; Tumor Cells, Cultured | 1998 |